- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Raynaud's Disease Secondary to Scleroderma in Chile
Total 19 results
-
Pontificia Universidad Catolica de ChileCompletedLupus Erythematosus, Systemic | Dermatomyositis | Ultrasound Therapy; Complications | Raynaud Disease | Raynaud Phenomenon Due to Trauma | System; SclerosisChile
-
University of ChileCompletedDental Caries Secondary to Acquired Defects of Tooth StructureChile
-
Pontificia Universidad Catolica de ChileLiga Panamericana de Asociaciones de Reumatologia (PANLAR)Not yet recruitingSystemic Sclerosis | CalcinosisChile
-
Pontificia Universidad Catolica de ChileFerring PharmaceuticalsCompletedSevere Aortic Stenosis | Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis | Heye´s SyndromeChile
-
Innobioscience SpAPontificia Universidad Catolica de Chile; University of Chile; Universidad Austral...UnknownMultiple Sclerosis, Secondary Progressive | Primary Progressive Multiple SclerosisChile
-
Medivation, Inc.PfizerTerminatedModerate to Severe AlzheimerChile, United Kingdom
-
Pontificia Universidad Catolica de ChileFormulario MAgistral Farmacias AhumadaCompletedXerostomia | Primary Sjogren | Secondary SjogrenChile
-
Boehringer IngelheimCompletedScleroderma, SystemicUnited States, Spain, United Kingdom, Belgium, Australia, Germany, Israel, China, Malaysia, Japan, Canada, Switzerland, France, Ireland, Greece, Norway, Portugal, Netherlands, Austria, Finland, Chile, Thailand, India, Argentina, Brazil, C... and more
-
SanofiActive, not recruitingSecondary Hyperparathyroidism-Chronic Kidney DiseaseUnited States, Chile
-
ActelionCompletedSystemic Sclerosis | UlcersCanada, United States, Belarus, Hungary, Croatia, Australia, Denmark, Ukraine, Bulgaria, Chile, Colombia, Czech Republic, Finland, Germany, India, Italy, Poland, Russian Federation
-
Sun Protection FoundationEnrolling by invitationSunburn | Sun Damaged Skin | Overexposure to Sun RaysUnited States, Chile, Peru
-
Boehringer IngelheimRecruitingScleroderma, SystemicUnited States, Belgium, Korea, Republic of, Australia, China, Taiwan, Spain, Israel, Japan, Mexico, Turkey, Germany, Italy, Brazil, France, Singapore, India, Philippines, United Kingdom, Switzerland, Finland, Greece, New Zealand, Denmark and more
-
AmgenRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicUnited States, Korea, Republic of, Germany, Spain, Italy, Israel, Japan, Serbia, Argentina, Greece, Mexico, Poland, Chile, Austria, France, Portugal, Romania, Switzerland, United Kingdom
-
BackBeat Medical IncMassachusetts General Hospital; MLM Medical Labs GmbH; nabios GmbHCompletedBradycardia | Atrioventricular Block | Hypertension Resistant to Conventional TherapyHungary, Austria, Chile, Latvia, Czechia, Lithuania, Netherlands
-
Antisoma ResearchUnknownSecondary Acute Myeloid Leukemia (Secondary AML, sAML)Korea, Republic of, United States, Spain, United Kingdom, Australia, Austria, Taiwan, Israel, Italy, Belgium, Germany, France, Romania, Estonia, Canada, Ukraine, Ecuador, Hungary, Poland, Chile, Argentina, Czech Republic, Russian Federation
-
Genentech, Inc.RecruitingIdiopathic Pulmonary Fibrosis | Systemic Sclerosis With Lung InvolvementUnited States, Korea, Republic of, Taiwan, Australia, Spain, Italy, Israel, Belgium, Argentina, France, Brazil, Greece, Poland, Chile, South Africa, Canada, New Zealand
-
Boehringer IngelheimCompletedStroke | Secondary PreventionKorea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina